NIDA - National Institute on Drug Abuse
In the US, methadone treatment for opioid use disorder (OUD) occurs within opioid treatment programs (OTPs). Methadone treatment decreases OUD-related mortality by 50%, but engagement and retention remain suboptimal. Strict restrictions, including on initial dose and take-home medication amounts, limit clinicians’ ability to partner with patients and address individual preferences. This contributes to reduced patient satisfaction, quality of life, suboptimal treatment retention, and clinician burnout. Additionally, daily methadone dose and take-home medication amounts vary by patient demographics suggesting suboptimal clinical decision making. Following COVID-19, the Substance Abuse and Mental Health Services Administration recommended “patient-provider shared decision making”, and made OTP regulations more flexible to facilitate shared decision making (SDM). The overarching goal of our research is to improve methadone treatment by establishing and sustaining greater person centered care within OTPs. The objective of the Personalized Methadone Treatment (PROMOTE) study is to adapt and test the impact of Implementation Facilitation (IF), a bundle of preparation, implementation, and sustainment strategies, on supporting systematic SDM implementation within OTPs. Our rationale for evaluating SDM implementation in a hybrid type 3 implementation-effectiveness trial is that it is indicated in the setting of incomplete effectiveness data when consensus guidelines, patient advocacy groups, and health system administrators all call for implementation. The primary objective will involve three specific aims: 1) adapt IF to support SDM implementation in OTPs; 2) determine the feasibility of executing and evaluating IF for SDM implementation in OTPs; and 3) evaluate the impact of IF on SDM implementation in OTPs. For Aim 1, we will use implementation mapping involving iterative rounds of focus groups at two OTPs, research team development, and advisory board review guided by the updated Consolidated Framework for Implementation Research. For Aim 2, we will conduct a 7-month pilot study of the preparation and implementation stages of the IF intervention at a single OTP, and concurrently collect 25 patient and 10 clinician semi-structured interviews and quantitative data necessary for Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) outcomes ascertainment. For Aim 3, we will conduct a pragmatic hybrid type 3 implementation-effectiveness stepped wedge cluster randomized trial in 10 OTPs in AZ, NY, and OH (i.e., strict versus less strict state regulation) using a mixed-methods evaluation of outcomes according to the RE-AIM framework, which includes assessment of sustainability. We will explore if reach of SDM, daily methadone dose, and take-home medication amounts vary by demographics. This study is innovative in that it implements SDM in a novel setting in a community engaged manner. It will also be high-impact by advancing patient-centered methadone care provision, positively impacting patients and the methadone OTP workforce.
Up to $488K
2027-08-31
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
One-time $749 fee · Includes AI drafting + templates + PDF export
Dynamic Cognitive Phenotypes for Prediction of Mental Health Outcomes in Serious Mental Illness
NIMH - National Institute of Mental Health — up to $18.3M
COORDINATED FACILITIES REQUIREMENTS FOR FY25 - FACILITIES TO I
NCI - National Cancer Institute — up to $15.1M
Leveraging Artificial Intelligence to Predict Mental Health Risk among Youth Presenting to Rural Primary Care Clinics
NIMH - National Institute of Mental Health — up to $15.0M
Feasibility of Genomic Newborn Screening Through Public Health Laboratories
OD - NIH Office of the Director — up to $14.4M
WOMEN'S HEALTH INITIATIVE (WHI) CLINICAL COORDINATING CENTER - TASK AREA A AND A2
NHLBI - National Heart Lung and Blood Institute — up to $10.2M
Metal Exposures, Omics, and AD/ADRD risk in Diverse US Adults
NIA - National Institute on Aging — up to $10.2M